MedPath

Development of a new adjunctive diagnostic method for Cushing's syndrome

Not Applicable
Conditions
Cunshing&#39
s syndrome
Registration Number
JPRN-UMIN000050256
Lead Sponsor
niversity of Miyazaki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
47
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients with highly active malignant tumors (2) Patients taking synthetic steroids (3) Patients with chronic renal failure, chronic heart failure, chronic obstructive pulmonary disease, liver cirrhosis, collagen disease, inflammatory bowel disease, neuromuscular disease, ascites effusion, or scoliosis as comorbid conditions (4) Patients who are heavy drinkers of alcohol or bedridden as their life history (5) Other patients who are deemed inappropriate as research subjects by the investigator.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnostic performance of Iliopsoas muscle-visceral fat ratio and PMI for Cushing's syndrome (ROC-AUC, sensitivity, specificity, etc.)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath